These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 10533775)

  • 1. Survival and prognostic factors in patients with resected epidermoid oesophageal carcinoma.
    Rosa AR; Gurski RR; Schirmer CC; Brentano L; Kruel CD
    Int Surg; 1999; 84(3):193-8. PubMed ID: 10533775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors predictive of prognosis after esophagectomy for squamous cell cancer.
    Li H; Zhang Q; Xu L; Chen Y; Wei Y; Zhou G
    J Thorac Cardiovasc Surg; 2009 Jan; 137(1):55-9. PubMed ID: 19154903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of factors influencing long-term survival after surgical resection for oesophageal squamous cell carcinoma.
    Kolh P; Honore P; Gielen JL; Degauque C; Azzam C; Legrand M; Jacquet N
    Acta Chir Belg; 1999; 99(3):113-8. PubMed ID: 10427345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor length as a prognostic factor in esophageal malignancy: univariate and multivariate survival analyses.
    Griffiths EA; Brummell Z; Gorthi G; Pritchard SA; Welch IM
    J Surg Oncol; 2006 Mar; 93(4):258-67. PubMed ID: 16496364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognosis of esophageal squamous cell carcinoma: analysis of clinicopathological and biological factors.
    Wang LS; Chow KC; Chi KH; Liu CC; Li WY; Chiu JH; Huang MH
    Am J Gastroenterol; 1999 Jul; 94(7):1933-40. PubMed ID: 10406262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathological determinants of survival in node-negative oesophageal cancer.
    Khan OA; Alexiou C; Soomro I; Duffy JP; Morgan WE; Beggs FD
    Br J Surg; 2004 Dec; 91(12):1586-91. PubMed ID: 15505868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improving the accuracy of TNM staging in esophageal cancer: a pathological review of resected specimens.
    Thompson SK; Ruszkiewicz AR; Jamieson GG; Esterman A; Watson DI; Wijnhoven BP; Lamb PJ; Devitt PG
    Ann Surg Oncol; 2008 Dec; 15(12):3447-58. PubMed ID: 18830669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic factors and family history for survival of esophageal squamous cell carcinoma patients after surgery.
    Yuequan J; Shifeng C; Bing Z
    Ann Thorac Surg; 2010 Sep; 90(3):908-13. PubMed ID: 20732516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pretreatment T3-4 stage is an adverse prognostic factor in patients with esophageal squamous cell carcinoma who achieve pathological complete response following preoperative chemoradiotherapy.
    Chao YK; Chan SC; Liu YH; Chen HW; Wan YL; Chang HK; Fan KH; Liu HP
    Ann Surg; 2009 Mar; 249(3):392-6. PubMed ID: 19247024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic factors of curatively resected esophageal carcinoma associated with multiple metastatic lymph nodes.
    Tabira Y; Sakaguchi T; Yoshida Y; Kuhara H; Kawasuji M
    Hepatogastroenterology; 2006; 53(71):715-9. PubMed ID: 17086875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammation-based prognostic score, prior to neoadjuvant chemoradiotherapy, predicts postoperative outcome in patients with esophageal squamous cell carcinoma.
    Kobayashi T; Teruya M; Kishiki T; Endo D; Takenaka Y; Tanaka H; Miki K; Kobayashi K; Morita K
    Surgery; 2008 Nov; 144(5):729-35. PubMed ID: 19081014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.
    Jin J; Liao Z; Zhang Z; Ajani J; Swisher S; Chang JY; Jeter M; Guerrero T; Stevens CW; Vaporciyan A; Putnam J; Walsh G; Smythe R; Roth J; Yao J; Allen P; Cox JD; Komaki R
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):427-36. PubMed ID: 15380576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. REG I expression predicts long-term survival among locally advanced thoracic squamous cell esophageal cancer patients treated with neoadjuvant chemoradiotherapy followed by esophagectomy.
    Motoyama S; Sugiyama T; Ueno Y; Okamoto H; Takasawa S; Nanjo H; Watanabe H; Maruyama K; Okuyama M; Ogawa J
    Ann Surg Oncol; 2006 Dec; 13(12):1724-31. PubMed ID: 17009160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Only pathologic complete response to neoadjuvant chemotherapy improves significantly the long term survival of patients with resectable esophageal squamous cell carcinoma: final report of a randomized, controlled trial of preoperative chemotherapy versus surgery alone.
    Ancona E; Ruol A; Santi S; Merigliano S; Sileni VC; Koussis H; Zaninotto G; Bonavina L; Peracchia A
    Cancer; 2001 Jun; 91(11):2165-74. PubMed ID: 11391598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of long-term survival after resection of esophageal carcinoma with nonregional nodal metastases.
    Lee PC; Port JL; Paul S; Stiles BM; Altorki NK
    Ann Thorac Surg; 2009 Jul; 88(1):186-92; discussion 192-3. PubMed ID: 19559222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neoadjuvant chemoradiotherapy for locally advanced esophageal cancer: experience at a single institution.
    Malaisrie SC; Untch B; Aranha GV; Mohideen N; Hantel A; Pickleman J
    Arch Surg; 2004 May; 139(5):532-8; discussion 538-9. PubMed ID: 15136354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The degree of circumferential tumour involvement as a prognostic factor in oesophageal cancer.
    Sillah K; Pritchard SA; Watkins GR; McShane J; West CM; Page R; Welch IM
    Eur J Cardiothorac Surg; 2009 Aug; 36(2):368-73. PubMed ID: 19318270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors affecting postoperative course and survival after en bloc resection for esophageal carcinoma.
    Mariette C; Taillier G; Van Seuningen I; Triboulet JP
    Ann Thorac Surg; 2004 Oct; 78(4):1177-83. PubMed ID: 15464466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salvage esophagectomy after definitive chemoradiotherapy for thoracic esophageal cancer.
    Miyata H; Yamasaki M; Takiguchi S; Nakajima K; Fujiwara Y; Nishida T; Mori M; Doki Y
    J Surg Oncol; 2009 Nov; 100(6):442-6. PubMed ID: 19653262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment outcome and recursive partitioning analysis-based prognostic factors in patients with esophageal squamous cell carcinoma receiving preoperative chemoradiotherapy.
    Kim MK; Kim SB; Ahn JH; Kim YH; Kim JH; Jung HY; Lee GH; Choi KD; Song HY; Shin JH; Cho KJ; Ryu JS; Park SI
    Int J Radiat Oncol Biol Phys; 2008 Jul; 71(3):725-34. PubMed ID: 18164836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.